Agarwal Pharchem India Private Limited, a under process of striking off private limited company, was established on 01 November 2001 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2001PTC133827. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.80 M.
It upholds a compliant status. Its leadership includes Mamta Agarwal (Director), Sanjay Kailashchandra Agarwal (Managing Director). Past directors included Narendra Kumar Biharidas Gupta, Vasudeo Pandurang Shiralkar, Sunil Agarwal. It holds no open charges and ₹9.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 603, Six Floor, D Definity Road No 1 J P Road, Goregaon (East), Mumbai, Maharashtra, 400063.
U24230MH2001PTC133827
133827
01 November 2001
₹1.00 M
₹0.80 M
Roc Mumbai
Unlisted
Under Process Of Striking Off
Explore comprehensive insights into Agarwal Pharchem India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mamta Agarwal | Director | 01 Nov 2001 | Current |
| Sanjay Kailashchandra Agarwal | Managing Director | 01 Nov 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Jan 2017 | Past |
| Pramod Abcsdd | Director | 27 Dec 2017 | Past |
| Pramod Abcsdd | Director | 20 Jan 2017 | Past |
| Pramod Abcsdd | Director | 20 Jan 2017 | Past |
| Pramod Abcsdd | Director | 20 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Agarwal Pharchem India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 142.89% decrease in profit. The company's net worth dipped by a decrease of 6.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Agarwal Pharchem India had a promoter holding of 62.12% and a public holding of 37.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹9,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2010 | The Saraswat Cooperative Bank Ltd | ₹4.00 M | Satisfied |
| 11 Jul 2005 | The Saraswat Co-Op Bank Ltd | ₹5.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Agarwal Pharchem India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Agarwal Pharchem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agarwal Pharchem India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Agarwal Pharchem India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Agarwal Pharchem India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge registered on 09 Mar 2010 via Charge ID 10212225 with The Saraswat Cooperative Bank Ltd was fully satisfied on 21 Dec 2012. was recorded as a recent event.
Progress on A charge registered on 11 Jul 2005 via Charge ID 90349300 with The Saraswat Co-Op Bank Ltd was fully satisfied on 21 Dec 2012. was documented.
The activity A charge with The Saraswat Cooperative Bank Ltd amounted to Rs. 4.00 M with Charge ID 10212225 was registered on 09 Mar 2010. was completed.
Progress on A charge with The Saraswat Co-Op Bank Ltd of Rs. 5.50 M registered on 11 Jul 2005 with Charge ID 90349300 was modified on 31 Mar 2009. was documented.
The CIN of Agarwal Pharchem India Private Limited is U24230MH2001PTC133827.
Agarwal Pharchem India Private Limited is headquartered at 603, Six Floor, D Definity Road No 1 J P Road, Goregaon (East), Mumbai, Maharashtra, 400063.
Agarwal Pharchem India Private Limited was incorporated on 01 November 2001.
The current directors of Agarwal Pharchem India Private Limited are
The primary industry of Agarwal Pharchem India Private Limited is Pharma.
Agarwal Pharchem India Private Limited is unlisted.
The authorized capital of Agarwal Pharchem India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.80 M.
The compliance status of Agarwal Pharchem India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX